Standout Papers
Citation Impact
3 by Nobel laureates 20 from Science/Nature 84 standout
Citing Papers
Colorectal cancer
2024 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
Works of Y. Bécouarn being referenced
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Randomized phase II trial comparing folfirinox (5FU/leucovorin [LV], irinotecan [I] and oxaliplatin [O]) vs gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA). First results of the ACCORD 11 trial
2007
Author Peers
| Author | Oncology | PRM | Surgery | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Y. Bécouarn | 6868 | 2169 | 2261 | 84 | 7.9k | |
| Erica S. Savig | 86 | 10 | 12 | 5 | 533 | |
| Akira Shiraki | 49 | 299 | 42 | 30 | 504 | |
| Mikhaila Burgess | 1 | 6 | 273 | |||
| Bradley M. Ratliff | 34 | 644 | ||||
| Patricia P. Mahlstedt | 1 | 3 | 1 | 7 | 496 |
All Works
Loading papers...